| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A Markov decision analysis of allogeneic hematopoietic cell transplantation versus chemotherapy in patients with acute myeloid leukemia in first remission.
|
Blood
|
2010
|
1.64
|
|
2
|
Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases.
|
Clin Cancer Res
|
2004
|
1.53
|
|
3
|
Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse.
|
Haematologica
|
2010
|
1.23
|
|
4
|
Preengraftment serum C-reactive protein (CRP) value may predict acute graft-versus-host disease and nonrelapse mortality after allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2008
|
1.15
|
|
5
|
Hyperglycemia during the neutropenic period is associated with a poor outcome in patients undergoing myeloablative allogeneic hematopoietic stem cell transplantation.
|
Transplantation
|
2007
|
1.15
|
|
6
|
Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
|
Cancer Res
|
2004
|
1.12
|
|
7
|
Impact of T cell chimerism on clinical outcome in 117 patients who underwent allogeneic stem cell transplantation with a busulfan-containing reduced-intensity conditioning regimen.
|
Biol Blood Marrow Transplant
|
2008
|
1.06
|
|
8
|
Regular dose of gemcitabine induces an increase in CD14+ monocytes and CD11c+ dendritic cells in patients with advanced pancreatic cancer.
|
Jpn J Clin Oncol
|
2009
|
1.05
|
|
9
|
Phase 1 trial of Wilms tumor 1 (WT1) peptide vaccine and gemcitabine combination therapy in patients with advanced pancreatic or biliary tract cancer.
|
J Immunother
|
2011
|
1.04
|
|
10
|
Expansion of alpha-galactosylceramide-stimulated Valpha24+ NKT cells cultured in the absence of animal materials.
|
J Immunother
|
2005
|
0.99
|
|
11
|
Allogeneic haematopoietic stem cell transplantation for the treatment of adult T-cell leukaemia/lymphoma.
|
Br J Haematol
|
2003
|
0.99
|
|
12
|
Myeloablative allogeneic hematopoietic stem cell transplantation for non-Hodgkin lymphoma: a nationwide survey in Japan.
|
Blood
|
2006
|
0.98
|
|
13
|
Comparison of allogeneic hematopoietic cell transplantation and chemotherapy in elderly patients with non-M3 acute myelogenous leukemia in first complete remission.
|
Biol Blood Marrow Transplant
|
2010
|
0.97
|
|
14
|
A prospective trial to evaluate the safety and efficacy of pravastatin for the treatment of refractory chronic graft-versus-host disease.
|
Transplantation
|
2005
|
0.96
|
|
15
|
Response-oriented preemptive therapy against cytomegalovirus disease with low-dose ganciclovir: a prospective evaluation.
|
Transplantation
|
2002
|
0.96
|
|
16
|
Impact of human leucocyte antigen mismatch on graft-versus-host disease and graft failure after reduced intensity conditioning allogeneic haematopoietic stem cell transplantation from related donors.
|
Br J Haematol
|
2005
|
0.95
|
|
17
|
Comparable antileukemia/lymphoma effects in nonremission patients undergoing allogeneic hematopoietic cell transplantation with a conventional cytoreductive or reduced-intensity regimen.
|
Biol Blood Marrow Transplant
|
2007
|
0.93
|
|
18
|
Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy.
|
Br J Haematol
|
2002
|
0.93
|
|
19
|
Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
|
Br J Haematol
|
2005
|
0.93
|
|
20
|
Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis.
|
Br J Haematol
|
2006
|
0.90
|
|
21
|
Feasibility of reduced-intensity cord blood transplantation as salvage therapy for graft failure: results of a nationwide survey of adult patients.
|
Biol Blood Marrow Transplant
|
2010
|
0.90
|
|
22
|
Clinical response in Japanese metastatic melanoma patients treated with peptide cocktail-pulsed dendritic cells.
|
J Transl Med
|
2005
|
0.89
|
|
23
|
Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
|
Transplantation
|
2003
|
0.89
|
|
24
|
Freeze-thawing procedures have no influence on the phenotypic and functional development of dendritic cells generated from peripheral blood CD14+ monocytes.
|
J Immunother
|
2003
|
0.88
|
|
25
|
Possible benefits of high-dose chemotherapy as intensive consolidation in patients with high-risk rhabdomyosarcoma who achieve complete remission with conventional chemotherapy.
|
Pediatr Hematol Oncol
|
2003
|
0.88
|
|
26
|
Allogeneic hematopoietic stem cell transplantation with a reduced-intensity conditioning regimen for treatment of metastatic renal cell carcinoma: single institution experience with a minimum 1-year follow-up.
|
Exp Hematol
|
2004
|
0.86
|
|
27
|
The role of PGE(2) in the differentiation of dendritic cells: how do dendritic cells influence T-cell polarization and chemokine receptor expression?
|
Stem Cells
|
2002
|
0.86
|
|
28
|
Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
|
Immunology
|
2005
|
0.86
|
|
29
|
Monitoring of WT1-specific cytotoxic T lymphocytes after allogeneic hematopoietic stem cell transplantation.
|
Int J Cancer
|
2006
|
0.85
|
|
30
|
Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential.
|
Exp Hematol
|
2003
|
0.84
|
|
31
|
Prospective trial of high-dose chemotherapy followed by infusions of peripheral blood stem cells and dose-escalated donor lymphocytes for relapsed leukemia after allogeneic stem cell transplantation.
|
Int J Hematol
|
2005
|
0.84
|
|
32
|
Chest computed tomography of late invasive aspergillosis after allogeneic hematopoietic stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2005
|
0.83
|
|
33
|
Effect of granulocyte colony-stimulating factor on bone metabolism during peripheral blood stem cell mobilization.
|
Int J Hematol
|
2003
|
0.83
|
|
34
|
Incidence of invasive aspergillosis after allogeneic hematopoietic stem cell transplantation with a reduced-intensity regimen compared with transplantation with a conventional regimen.
|
Biol Blood Marrow Transplant
|
2004
|
0.83
|
|
35
|
Outcome of 93 patients with relapse or progression following allogeneic hematopoietic cell transplantation.
|
Am J Hematol
|
2009
|
0.83
|
|
36
|
Outcomes of patients with acute leukaemia who relapsed after reduced-intensity stem cell transplantation from HLA-identical or one antigen-mismatched related donors.
|
Br J Haematol
|
2005
|
0.82
|
|
37
|
Early central nervous system complications after reduced-intensity stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2004
|
0.82
|
|
38
|
Identification of HLA-A24-restricted CTL epitope encoded by the matrix protein pp65 of human cytomegalovirus.
|
Immunol Lett
|
2002
|
0.81
|
|
39
|
A potential activity of valproic acid in the stimulation of interleukin-3-mediated megakaryopoiesis and erythropoiesis.
|
Exp Hematol
|
2010
|
0.81
|
|
40
|
Identification of serum proteins related to adverse effects induced by docetaxel infusion from protein expression profiles of serum using SELDI ProteinChip system.
|
Anticancer Res
|
2005
|
0.81
|
|
41
|
Therapeutic potential of a reduced-intensity preparative regimen for allogeneic transplantation with cladribine, busulfan, and antithymocyte globulin against advanced/refractory acute leukemia/lymphoma.
|
Clin Cancer Res
|
2002
|
0.81
|
|
42
|
Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
|
Am J Hematol
|
2007
|
0.80
|
|
43
|
Reduced-intensity hematopoietic stem cell transplantation (RIST) for solid malignancies.
|
Jpn J Clin Oncol
|
2004
|
0.80
|
|
44
|
TRALI after the infusion of marrow cells in a patient with acute lymphoblastic leukemia.
|
Transfusion
|
2003
|
0.79
|
|
45
|
Cytokine production and migration of in vitro-expanded NK1.1(-) invariant Valpha14 natural killer T (Valpha14i NKT) cells using alpha-galactosylceramide and IL-2.
|
Immunol Lett
|
2005
|
0.79
|
|
46
|
Positive impact of maintaining minimal caloric intake above 1.0 x basal energy expenditure on the nutritional status of patients undergoing allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2009
|
0.79
|
|
47
|
Interleukin (IL)-4 promotes T helper type 2-biased natural killer T (NKT) cell expansion, which is regulated by NKT cell-derived interferon-gamma and IL-4.
|
Immunology
|
2007
|
0.79
|
|
48
|
Hematopoietic stem cell transplantation for therapy-related myelodysplastic syndrome and acute leukemia: a single-center analysis of 47 patients.
|
Int J Hematol
|
2010
|
0.79
|
|
49
|
Generation of cytotoxic donor CD8+ T cells against relapsing leukemic cells following allogeneic transplantation by stimulation with leukemic cell- or leukemic lysate pulsed donor cell-derived dendritic cells.
|
Leuk Res
|
2004
|
0.79
|
|
50
|
Development of early neutropenic fever, with or without bacterial infection, is still a significant complication after reduced-intensity stem cell transplantation.
|
Biol Blood Marrow Transplant
|
2004
|
0.79
|
|
51
|
Cryopreservation of mobilized blood stem cells at a higher cell concentration without the use of a programmed freezer.
|
Ann Hematol
|
2003
|
0.78
|
|
52
|
Reduced-intensity allogeneic hematopoietic stem-cell transplantation as an immunotherapy for metastatic colorectal cancer.
|
Transplantation
|
2004
|
0.78
|
|
53
|
Impact of stem cell source and conditioning regimen on erythrocyte recovery kinetics after allogeneic haematopoietic stem cell transplantation from an ABO-incompatible donor.
|
Br J Haematol
|
2002
|
0.78
|
|
54
|
Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients.
|
Br J Haematol
|
2004
|
0.78
|
|
55
|
T-cell large granular lymphocyte leukemia of donor origin after cord blood transplantation.
|
Clin Lymphoma Myeloma
|
2007
|
0.78
|
|
56
|
Unrelated-donor bone marrow transplantation with a conditioning regimen including fludarabine, busulfan, and 4 Gy total body irradiation.
|
Int J Hematol
|
2007
|
0.78
|
|
57
|
Modulation of acute graft-versus-host disease and chimerism after adoptive transfer of in vitro-expanded invariant Valpha14 natural killer T cells.
|
Immunol Lett
|
2006
|
0.77
|
|
58
|
Nutritional support for patients suffering from intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
|
Am J Hematol
|
2006
|
0.77
|
|
59
|
Cost and effectiveness of reduced-intensity and conventional allogeneic hematopoietic stem cell transplantation for acute myelogenous leukemia and myelodysplastic syndrome.
|
Support Care Cancer
|
2009
|
0.77
|
|
60
|
Increased expansion of V alpha 24+ T cells derived from G-CSF-mobilized peripheral blood stem cells as compared to peripheral blood mononuclear cells following alpha-galactosylceramide stimulation.
|
Cancer Sci
|
2003
|
0.77
|
|
61
|
EBV-positive Burkitt lymphoma as a late-onset posttransplantion lymphoproliferative disorder after allogeneic stem cell transplantation.
|
Int J Hematol
|
2004
|
0.77
|
|
62
|
The gastrointestinal tract is a common target of invasive aspergillosis in patients receiving cytotoxic chemotherapy for hematological malignancy.
|
Clin Infect Dis
|
2002
|
0.77
|
|
63
|
Fulminant septicemia caused by Bacillus cereus following reduced-intensity umbilical cord blood transplantation.
|
Haematologica
|
2005
|
0.77
|
|
64
|
Feasibility of acute physiology and chronic health evaluation (APACHE) II and III score-based screening in patients receiving allogeneic hematopoietic stem-cell transplantation.
|
Transplantation
|
2003
|
0.77
|
|
65
|
In vivo T-cell depletion with alemtuzumab in allogeneic hematopoietic stem cell transplantation: Combined results of two studies on aplastic anemia and HLA-mismatched haploidentical transplantation.
|
Am J Hematol
|
2013
|
0.76
|
|
66
|
Fatal hepatic failure associated with graft rejection following reduced-intensity stem-cell transplantation for chronic idiopathic myelofibrosis (CIMF).
|
Leuk Lymphoma
|
2004
|
0.76
|
|
67
|
Feasibility of early tapering of cyclosporine following reduced-intensity stem cell transplantation for advanced hematologic or solid malignancies.
|
Haematologica
|
2005
|
0.76
|
|
68
|
Efficient ex vivo expansion of Valpha24+ NKT cells derived from G-CSF-mobilized blood cells.
|
J Immunother
|
2006
|
0.76
|
|
69
|
Sustained molecular remission in a patient with CML in blastic crisis receiving dose-reduced hematopoietic stem-cell transplantation followed by early withdrawal of cyclosporine and prophylactic use of interferon-alpha.
|
Am J Hematol
|
2002
|
0.76
|
|
70
|
HLA-identical sibling peripheral blood stem cell transplantation in children and adolescents.
|
Biol Blood Marrow Transplant
|
2002
|
0.76
|
|
71
|
G-CSF priming in acute myelogenous leukemia.
|
N Engl J Med
|
2003
|
0.75
|
|
72
|
Reviparin after leg injury requiring immobilization.
|
N Engl J Med
|
2003
|
0.75
|
|
73
|
ZAP-70 in chronic lymphocytic leukemia.
|
N Engl J Med
|
2003
|
0.75
|
|
74
|
Infusion of donor lymphocytes expressing the herpes simplex virus thymidine kinase suicide gene for recurrent hematologic malignancies after allogeneic hematopoietic stem cell transplantation.
|
Int J Hematol
|
2015
|
0.75
|
|
75
|
Selective decontamination of digestive tract in intensive care.
|
Lancet
|
2003
|
0.75
|
|
76
|
Varicella vaccine in recipients of hematopoietic-cell transplants.
|
N Engl J Med
|
2002
|
0.75
|
|
77
|
Chimerism induction and delayed onset of sytomegalovirus (CMV) infection after allogeneic reduced-intensity stem cell transplantation (RIST).
|
Blood
|
2002
|
0.75
|
|
78
|
[Clinical safety data management in company non-sponsored trials].
|
Nihon Rinsho
|
2003
|
0.75
|
|
79
|
Hematopoietic and immune recovery after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation in a pediatric population.
|
Pediatr Transplant
|
2002
|
0.75
|
|
80
|
The feasibility of reduced-intensity allogeneic hematopoietic stem cell transplantation from a related donor with HLA one-antigen with or without one-allele mismatch.
|
Haematologica
|
2003
|
0.75
|
|
81
|
Non-myeloablative hematopoietic stem cell transplantation for the treatment of adult T-cell lymphoma in a patient with advanced hepatic impairment.
|
Leuk Lymphoma
|
2003
|
0.75
|
|
82
|
Real-time in vivo cellular imaging of graft-versus-host disease and its reaction to immunomodulatory reagents.
|
Immunol Lett
|
2012
|
0.75
|
|
83
|
Reduced-intensity unrelated donor bone marrow transplantation for hematologic malignancies.
|
Int J Hematol
|
2008
|
0.75
|
|
84
|
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.
|
Am J Hematol
|
2012
|
0.75
|
|
85
|
Fatal deep vein thrombosis after allogeneic reduced intensity hematopoietic stem cell transplantation for the treatment of metastatic gastric cancer.
|
Ann Hematol
|
2003
|
0.75
|
|
86
|
[Reduced-intensity allogeneic hematopoietic stem cell transplantation (mini-transplantation) for solid tumors].
|
Gan To Kagaku Ryoho
|
2002
|
0.75
|
|
87
|
Characterization of acute graft-versus-host disease following reduced-intensity stem-cell transplantation from an HLA-identical related donor.
|
Am J Hematol
|
2008
|
0.75
|
|
88
|
Intensive multimodality therapy including paclitaxel and reduced-intensity allogeneic hematopoietic stem cell transplantation in the treatment of adrenal cancer with multiple metastases.
|
Int J Clin Oncol
|
2006
|
0.75
|
|
89
|
U5A2-13, an antigen originally found on mouse NK-like T cells, is an early inducible cell surface antigen during lymphoid activation.
|
Cell Immunol
|
2003
|
0.75
|
|
90
|
Development of reduced-intensity hematopoietic stem cell transplantation in the National Cancer Center Hospital, Japan.
|
Ther Apher Dial
|
2003
|
0.75
|
|
91
|
Life-threatening hypothyroidism associated with administration of cyclosporine in a patient treated with reduced-intensity hematopoietic stem-cell transplantation for metastatic renal-cell carcinoma.
|
Transplantation
|
2003
|
0.75
|
|
92
|
Balance between acute graft-versus-host disease and graft-versus-tumor effect after reduced-intensity transplantation for metastatic renal cell carcinoma.
|
Hematol J
|
2004
|
0.75
|
|
93
|
Impact of graft-versus-host disease in reduced-intensity stem cell transplantation (RIST) for patients with haematological malignancies.
|
Br J Haematol
|
2003
|
0.75
|
|
94
|
Coincidental outbreak of methicillin-resistant Staphylococcus aureus in a hematopoietic stem cell transplantation unit.
|
Am J Hematol
|
2006
|
0.75
|
|
95
|
Successful umbilical cord blood transplantation in an infant with ALL failing initial autologous peripheral blood stem cell transplantation.
|
Med Pediatr Oncol
|
2002
|
0.75
|
|
96
|
Limited efficacy of lamivudine against hepatitis B virus infection in allogeneic hematopoietic stem cell transplant recipients.
|
Transplantation
|
2002
|
0.75
|
|
97
|
Early detection of plasma cytomegalovirus DNA by real-time PCR after allogeneic hematopoietic stem cell transplantation.
|
Tohoku J Exp Med
|
2006
|
0.75
|
|
98
|
Diagnosis and evaluation of intestinal graft-versus-host disease after allogeneic hematopoietic stem cell transplantation following reduced-intensity and myeloablative conditioning regimens.
|
Int J Hematol
|
2013
|
0.75
|
|
99
|
The mouse natural killer T cell-associated antigen recognized by U5A2-13 monoclonal antibody is intercellular adhesion molecule-1.
|
Immunol Lett
|
2004
|
0.75
|
|
100
|
[Present status and future prospects in reduced intensity stem cell transplantation].
|
Nihon Naika Gakkai Zasshi
|
2005
|
0.75
|